Daniel H. Atchley

548 total citations
19 papers, 423 citations indexed

About

Daniel H. Atchley is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Daniel H. Atchley has authored 19 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Immunology. Recurrent topics in Daniel H. Atchley's work include Mosquito-borne diseases and control (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Daniel H. Atchley is often cited by papers focused on Mosquito-borne diseases and control (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Daniel H. Atchley collaborates with scholars based in United States, Colombia and Venezuela. Daniel H. Atchley's co-authors include Gabriel Virella, Maria F. Lopes‐Virella, Danxia Zheng, Sinikka Koskinen, Nathan L. Alderson, Danelle Kenny, Suzanne R. Thorpe, Bruce R. Burnham, John H. Lee and Kathleen E. Ferris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Lipid Research and Diabetologia.

In The Last Decade

Daniel H. Atchley

19 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel H. Atchley United States 9 185 74 74 67 61 19 423
Liqun Wang China 10 84 0.5× 87 1.2× 64 0.9× 41 0.6× 86 1.4× 20 381
Yanfang Lu China 17 272 1.5× 279 3.8× 27 0.4× 38 0.6× 102 1.7× 30 832
Arielle Klepper United States 9 236 1.3× 169 2.3× 89 1.2× 52 0.8× 205 3.4× 15 692
Rosarita Amore Italy 15 55 0.3× 191 2.6× 38 0.5× 17 0.3× 139 2.3× 28 562
Ashley R. Burg United States 12 227 1.2× 210 2.8× 62 0.8× 10 0.1× 108 1.8× 19 605
Mitsuo Kitahara United States 11 68 0.4× 40 0.5× 33 0.4× 36 0.5× 117 1.9× 19 350
H.‐J. Lv China 12 254 1.4× 88 1.2× 37 0.5× 52 0.8× 71 1.2× 88 564
G A Warr United States 13 281 1.5× 166 2.2× 39 0.5× 14 0.2× 144 2.4× 16 794
Herman Mattie Netherlands 12 284 1.5× 137 1.9× 25 0.3× 21 0.3× 90 1.5× 22 673
Takeaki Nishibori Japan 12 231 1.2× 84 1.1× 36 0.5× 7 0.1× 54 0.9× 15 552

Countries citing papers authored by Daniel H. Atchley

Since Specialization
Citations

This map shows the geographic impact of Daniel H. Atchley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Atchley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Atchley more than expected).

Fields of papers citing papers by Daniel H. Atchley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Atchley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Atchley. The network helps show where Daniel H. Atchley may publish in the future.

Co-authorship network of co-authors of Daniel H. Atchley

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Atchley. A scholar is included among the top collaborators of Daniel H. Atchley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Atchley. Daniel H. Atchley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Atchley, Daniel H., et al.. (2023). Impact of a pharmacist-led, primary medication nonadherence intervention program on prescription fills in underserved patient populations. Journal of the American Pharmacists Association. 63(4). 1057–1063.e2. 3 indexed citations
3.
Murphy, Michael A., et al.. (2017). Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers. Journal of Clinical Pharmacy and Therapeutics. 42(5). 547–553. 10 indexed citations
4.
Lee, Yoon-Jung, et al.. (2015). Time-kill Kinetics of a Novel Antimicrobial Silver Wound Gel Against Select Wound Pathogens.. PubMed. 27(12). 336–46. 3 indexed citations
5.
Atchley, Daniel H., et al.. (2015). Impact ofUGT2B17Gene Deletion on the Pharmacokinetics of 17-Hydroexemestane in Healthy Volunteers. The Journal of Clinical Pharmacology. 56(7). 875–884. 17 indexed citations
7.
Atchley, Daniel H., et al.. (2013). Analysis of real time PCR amplification efficiencies from three genomic region of dengue virus.. PubMed. 54(1). 5–19. 2 indexed citations
8.
Atchley, Daniel H., et al.. (2007). Indirect detection of Bacillus anthracis using real-time PCR to detect amplified gamma phage DNA. Journal of Microbiological Methods. 68(3). 651–653. 22 indexed citations
9.
Blow, Jamie A., Michael J. Turell, David E. Bowles, et al.. (2005). Rapid Identification of Dengue Virus by Reverse Transcription-Polymerase Chain Reaction Using Field-Deployable Instrumentation. Military Medicine. 170(12). 1053–1059. 8 indexed citations
10.
Bowles, David E., et al.. (2005). Identification ofAedes aegyptiand Its Respective Life Stages by Real-Time Polymerase Chain Reaction. Military Medicine. 170(12). 1060–1065. 5 indexed citations
11.
Daum, Luke T., Keying Ye, James P. Chambers, et al.. (2004). Comparison of TaqMan™ and Epoch Dark Quenchers™ during real-time reverse transcription PCR. Molecular and Cellular Probes. 18(3). 207–209. 8 indexed citations
12.
Atchley, Daniel H., et al.. (2004). Identification ofFrancisella tularensisUsing Real-Time Fluorescence Polymerase Chain Reaction. Military Medicine. 169(4). 330–333. 8 indexed citations
13.
Virella, Gabriel, et al.. (2003). Autoimmune response to advanced glycosylation end-products of human LDL. Journal of Lipid Research. 44(3). 487–493. 72 indexed citations
14.
Atchley, Daniel H., Maria F. Lopes‐Virella, Danxia Zheng, Danelle Kenny, & Gabriel Virella. (2002). Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia. 45(11). 1562–1571. 52 indexed citations
15.
Virella, Gabriel, Daniel H. Atchley, Sinikka Koskinen, Danxia Zheng, & Maria F. Lopes‐Virella. (2002). Proatherogenic and Proinflammatory Properties of Immune Complexes Prepared with Purified Human oxLDL Antibodies and Human oxLDL. Clinical Immunology. 105(1). 81–92. 82 indexed citations
16.
Atchley, Daniel H., C. Anne Morrison, Seetal Dodd, et al.. (2002). One step purification of alpha1-acid glycoprotein from human plasma. Journal of Chromatography B. 784(1). 33–38. 8 indexed citations
18.
Burnham, Bruce R., et al.. (1998). Prevalence of fecal shedding of Salmonella organisms among captive green iguanas and potential public health implications. Journal of the American Veterinary Medical Association. 213(1). 48–50. 49 indexed citations
19.
Hirsch, Irl B., Daniel H. Atchley, Emily Tsai, Robert F. Labbé, & Alan Chait. (1998). Ascorbic Acid Clearance in Diabetic Nephropathy. Journal of Diabetes and its Complications. 12(5). 259–263. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026